Correlation Between Milestone Pharmaceuticals and Fate Therapeutics
Can any of the company-specific risk be diversified away by investing in both Milestone Pharmaceuticals and Fate Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Milestone Pharmaceuticals and Fate Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Milestone Pharmaceuticals and Fate Therapeutics, you can compare the effects of market volatilities on Milestone Pharmaceuticals and Fate Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Milestone Pharmaceuticals with a short position of Fate Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Milestone Pharmaceuticals and Fate Therapeutics.
Diversification Opportunities for Milestone Pharmaceuticals and Fate Therapeutics
-0.55 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Milestone and Fate is -0.55. Overlapping area represents the amount of risk that can be diversified away by holding Milestone Pharmaceuticals and Fate Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Fate Therapeutics and Milestone Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Milestone Pharmaceuticals are associated (or correlated) with Fate Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Fate Therapeutics has no effect on the direction of Milestone Pharmaceuticals i.e., Milestone Pharmaceuticals and Fate Therapeutics go up and down completely randomly.
Pair Corralation between Milestone Pharmaceuticals and Fate Therapeutics
Given the investment horizon of 90 days Milestone Pharmaceuticals is expected to generate 0.52 times more return on investment than Fate Therapeutics. However, Milestone Pharmaceuticals is 1.92 times less risky than Fate Therapeutics. It trades about 0.2 of its potential returns per unit of risk. Fate Therapeutics is currently generating about 0.0 per unit of risk. If you would invest 139.00 in Milestone Pharmaceuticals on September 3, 2024 and sell it today you would earn a total of 60.00 from holding Milestone Pharmaceuticals or generate 43.17% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Milestone Pharmaceuticals vs. Fate Therapeutics
Performance |
| Timeline |
| Milestone Pharmaceuticals |
| Fate Therapeutics |
Milestone Pharmaceuticals and Fate Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Milestone Pharmaceuticals and Fate Therapeutics
The main advantage of trading using opposite Milestone Pharmaceuticals and Fate Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Milestone Pharmaceuticals position performs unexpectedly, Fate Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fate Therapeutics will offset losses from the drop in Fate Therapeutics' long position.The idea behind Milestone Pharmaceuticals and Fate Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
| Fate Therapeutics vs. Seres Therapeutics | Fate Therapeutics vs. DiaMedica Therapeutics | Fate Therapeutics vs. Lyra Therapeutics | Fate Therapeutics vs. Centessa Pharmaceuticals PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Other Complementary Tools
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |